Literature DB >> 10516029

Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets.

A M Roque Afonso1, J Jiang, F Penin, C Tareau, D Samuel, M A Petit, H Bismuth, E Dussaix, C Féray.   

Abstract

The existence of an extrahepatic reservoir of hepatitis C virus (HCV) is suggested by differences in quasispecies composition between the liver, peripheral blood mononuclear cells, and serum. We studied HCV RNA compartmentalization in the plasma of nine patients, in CD19(+), CD8(+), and CD4(+) positively selected cells, and also in the negatively selected cell fraction (NF). HCV RNA was detected in all plasma samples, in seven of nine CD19(+), three of eight CD8(+), and one of nine CD4(+) cell samples, and in seven of eight NF cells. Cloning and sequencing of HVR1 in two patients showed a sequence grouping: quasispecies from a given compartment (all studied compartments for one patient and CD8(+) and NF for the other) were statistically more genetically like each other than like quasispecies from any other compartment. The characteristics of amino acid and nucleotide substitutions suggested the same structural constraints on HVR1, even in very divergent strains from the cellular compartments, and homogeneous selection pressure on the different compartments. These findings demonstrate the compartmental distribution of HCV quasispecies within peripheral blood cell subsets and have important implications for the study of extrahepatic HCV replication and interaction with the immune system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516029      PMCID: PMC112955     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  False detection of negative-strand hepatitis C virus RNA.

Authors:  P H McGuinness; G A Bishop; G W McCaughan; R Trowbridge; E J Gowans
Journal:  Lancet       Date:  1994-02-26       Impact factor: 79.321

2.  Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected].

Authors:  O Planz; P Seiler; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

3.  Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

Authors:  A Zibert; H Meisel; W Kraas; A Schulz; G Jung; M Roggendorf
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

4.  MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers.

Authors:  S Kumar; K Tamura; M Nei
Journal:  Comput Appl Biosci       Date:  1994-04

5.  Differences in hypervariable region 1 quasispecies of hepatitis C virus between human serum and peripheral blood mononuclear cells.

Authors:  K Fujii; K Hino; M Okazaki; M Okuda; S Kondoh; K Okita
Journal:  Biochem Biophys Res Commun       Date:  1996-08-23       Impact factor: 3.575

6.  Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein.

Authors:  P Farci; A Shimoda; D Wong; T Cabezon; D De Gioannis; A Strazzera; Y Shimizu; M Shapiro; H J Alter; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

7.  Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may not be reflected by analysis of circulating HCV virions.

Authors:  B Cabot; J I Esteban; M Martell; J Genescà; V Vargas; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells.

Authors:  M Willems; K Peerlinck; H Moshage; I Deleu; C Van den Eynde; J Vermylen; S H Yap
Journal:  J Med Virol       Date:  1994-03       Impact factor: 2.327

9.  Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2.

Authors:  T Mizutani; N Kato; S Saito; M Ikeda; K Sugiyama; K Shimotohno
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Detection of hepatitis C virus RNA in circulating immune complexes by RT-PCR.

Authors:  T Morita; H Hada; N Koide; H Shiraha; T Shinji; M Nakamura; K Ujike; M Wato; H Shimomura; T Tsuji
Journal:  Hepatogastroenterology       Date:  1996 May-Jun
View more
  38 in total

1.  Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.

Authors:  S Wünschmann; J D Medh; D Klinzmann; W N Schmidt; J T Stapleton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.

Authors:  F Penin; C Combet; G Germanidis; P O Frainais; G Deléage; J M Pawlotsky
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome.

Authors:  Gianguglielmo Zehender; Chiara De Maddalena; Flavia Bernini; Erika Ebranati; Giuseppe Monti; Piero Pioltelli; Massimo Galli
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a.

Authors:  C Sarrazin; D A Hendricks; F Sedarati; S Zeuzem
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  Genetic clustering of hepatitis C virus strains and severity of recurrent hepatitis after liver transplantation.

Authors:  M Gigou; A M Roque-Afonso; B Falissard; F Penin; E Dussaix; C Féray
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients.

Authors:  Tetsuro Suzuki; Kazuhiko Omata; Tazuko Satoh; Takahiro Miyasaka; Chiaki Arai; Munehiro Maeda; Tomonori Matsuno; Tatsuo Miyamura
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants.

Authors:  Daniel M Forton; Peter Karayiannis; Nadiya Mahmud; Simon D Taylor-Robinson; Howard C Thomas
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection.

Authors:  Jason T Blackard; Yoichi Hiasa; Laura Smeaton; Denise J Jamieson; Irma Rodriguez; Kenneth H Mayer; Raymond T Chung
Journal:  J Infect Dis       Date:  2007-05-02       Impact factor: 5.226

9.  Hepatitis C virus RNA quantitation in venous and capillary small-volume whole-blood samples.

Authors:  Tony Bruns; Katrin Steinmetzer; Eugen Ermantraut; Andreas Stallmach
Journal:  J Clin Microbiol       Date:  2009-08-19       Impact factor: 5.948

10.  L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.

Authors:  Emmanuel G Cormier; Robert J Durso; Fotini Tsamis; Lise Boussemart; Catherine Manix; William C Olson; Jason P Gardner; Tatjana Dragic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.